15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 20 firms covering Incyte Corporation, 9 rate it Buy or better, 11 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $90.00 to $140.00, a moderate spread. The average target of $112.11 sits 14% below the current $129.97. Sentiment has drifted a little more constructive lately, with Sell ratings easing from 1 to 0 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-3.45 next quarter toward $9.01 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS20 ratings
Moderate Buy
Strong Buy00%
Buy945%
Hold1155%
Sell00%
Strong Sell00%
Based on 20 analysts giving stock ratings to Incyte Corporation.
As of Jul, 8 of 19 firms rate INCY a Buy (11 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
INCY EPS & revenue forecast
EPS · NEXT QUARTER
$-3.45
Range $-4.14 – $-2.85 · 8 analysts · -253% YoY
Next period, 8 analysts expect Incyte Corporation to earn $-3.45 a share (range $-4.14 – $-2.85), versus $2.26 a year earlier. Full-year consensus is $2.75, growing to $9.01 the year after.
REVENUE · NEXT QUARTER
$1.5B
Range $1.4B – $1.5B · 8 analysts · +7% YoY
Revenue is expected to reach $1.5B (range $1.4B – $1.5B), +6.7% year-over-year. Full-year consensus is $5.7B, rising to $6.2B next year.
Top analysts covering Incyte Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on INCY.
#1
Michael Schmidt
Guggenheim · Rank #1
Buy
$136.00+4.6% to target
Overall win rate
55%
+ Follow
#2
Jessica Fye
JP Morgan · Rank #64
Hold
$110.00-15.4% to target
Overall win rate
52%
+ Follow
#3
Mitchell Kapoor
HC Wainwright & Co. · Rank #165
Buy
$140.00+7.7% to target
Overall win rate
34%
+ Follow
#4
Andrew Berens
Leerink Partners · Rank #167
Buy
$103.00-20.8% to target
Overall win rate
50%
+ Follow
#5
TA
Tazeen Ahmad
B of A Securities · Rank #275
Buy
$124.00-4.6% to target
Overall win rate
41%
+ Follow
INCY stock forecast FAQ
What is INCY's average 12-month price target?+
The 18 analysts with a live target average $112.11 for Incyte Corporation over the next 12 months, ranging from a $140.00 high to a $90.00 low.
Is INCY stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 20 analyst ratings, 9 are Buy or Strong Buy, 11 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for INCY?+
The Street-high target is $140.00 (HC Wainwright & Co.), and the Street-low is $90.00 (Oppenheimer). The average of all 18 active targets is $112.11.
How many Wall Street analysts cover INCY?+
20 analysts have an active rating on Incyte Corporation, and 18 firms carry a live 12-month price target.
Who is the most accurate analyst covering INCY?+
Among analysts who currently cover INCY, Michael Schmidt of Guggenheim has the strongest overall Quantellect track record (Rank #1). Their current call is Buy with a $136.00 target.
What is Incyte Corporation's projected EPS for next quarter?+
The consensus estimate is $-3.45 per share (range $-4.14 – $-2.85) across 8 analysts. Full-year EPS is projected at $2.75, rising to $9.01 the following year.
How much revenue is Incyte Corporation expected to report next quarter?+
Consensus revenue is $1.5B (range $1.4B – $1.5B). Full-year revenue is projected at $5.7B, growing to $6.2B next year.
Have analysts been upgrading or downgrading INCY lately?+
As of Jul, 8 of 19 firms rate INCY a Buy (11 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their INCY calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
